Michael Lichtenauer

4.2k total citations
151 papers, 2.6k citations indexed

About

Michael Lichtenauer is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Michael Lichtenauer has authored 151 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Cardiology and Cardiovascular Medicine, 40 papers in Surgery and 27 papers in Epidemiology. Recurrent topics in Michael Lichtenauer's work include Cardiac Valve Diseases and Treatments (20 papers), Cardiovascular Function and Risk Factors (14 papers) and IL-33, ST2, and ILC Pathways (12 papers). Michael Lichtenauer is often cited by papers focused on Cardiac Valve Diseases and Treatments (20 papers), Cardiovascular Function and Risk Factors (14 papers) and IL-33, ST2, and ILC Pathways (12 papers). Michael Lichtenauer collaborates with scholars based in Austria, Germany and Sweden. Michael Lichtenauer's co-authors include Christian Jung, Uta C. Hoppe, Bernhard Wernly, Hendrik Jan Ankersmit, Marcus Franz, Konrad Höetzenecker, P. Christian Schulze, Alexander Lauten, Vera Paar and Malte Kelm and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael Lichtenauer

147 papers receiving 2.5k citations

Peers

Countries citing papers authored by Michael Lichtenauer

Since Specialization

Citations

This map shows the geographic impact of Michael Lichtenauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lichtenauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lichtenauer more than expected).

Fields of papers citing papers by Michael Lichtenauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lichtenauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lichtenauer. The network helps show where Michael Lichtenauer may publish in the future.

Co-authorship network of co-authors of Michael Lichtenauer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lichtenauer. A scholar is included among the top collaborators of Michael Lichtenauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lichtenauer. Michael Lichtenauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction 2024 ·SHILAP Revista de lepidopterología ·Tetiana A. Berezina, (unknown), Michael Lichtenauer, Alexander Е. Berezin	3
2	Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation 2024 ·Heart Rhythm O2 ·(unknown), (unknown), Christoph Edlinger, Vera Paar, (unknown), Michael Lichtenauer, Anja Haase‐Fielitz, Martin Seifert, Christian Butter	0
3	Life cycle and post-mortem ingrowth patterns of a leadless pacemaker system 2024 ·EP Europace ·Hermann Blessberger, (unknown), Claudia Große, (unknown), (unknown), (unknown), Julian Maier, Stefan Schwarz, Christian Reiter, (unknown), Michael Lichtenauer, Joerg Kellermair, Juergen Kammler, Karim Saleh, Clemens Steinwender	3
4	Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction 2024 ·Biomedicines ·Tetiana A. Berezina, (unknown), Uta C. Hoppe, Michael Lichtenauer, Alexander Е. Berezin	3
5	Cardiopulmonary long-term effects 6, 18 and 30 months after severe COVID-19 infection 2024 ·European Heart Journal ·(unknown), (unknown), (unknown), (unknown), (unknown), Maike Kahr, (unknown), (unknown), (unknown), Michael Lichtenauer, Alexander Zoufaly, Rudolf Valenta, Christian Krestan, Christoph Wenisch, (unknown)	0
6	Diverging Concentrations of Soluble Suppression of Tumorigenicity (sST2) Analyzed by two Different Assays - a Limitation for its use in Clinical Practice? 2023 ·Clinical Laboratory ·Moritz Mirna, Vera Paar, (unknown), Albert Topf, Uta C. Hoppe, Michael Lichtenauer	1
7	RANTES and CD40L under Conditions of Long-Term Physical Exercise: A Potential Link to Adaptive Immunity 2022 ·International Journal of Environmental Research and Public Health ·Max Lenz, Robert Schönbauer, Stefan Stojković, (unknown), (unknown), Michael Lichtenauer, Vera Paar, (unknown), Monika Fritzer‐Szekeres, Jeanette Strametz‐Juranek, Senta Graf, (unknown)	2
8	Psychosocial Factors, Mental Health, and Coordination Capacity in Patients with Heart Failure with Preserved Ejection Fraction Compared with Heart Failure with Reduced Ejection Fraction 2021 ·ESC Heart Failure ·Tarek Bekfani, (unknown), Steffen Derlien, Ali Hamadanchi, (unknown), Gudrun Dannberg, Michael Lichtenauer, U. Smolenski, Gabriele Lehmann, Sven Möbius‐Winkler, P. Christian Schulze	14
9	Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis 2021 ·Scientific Reports ·Moritz Mirna, (unknown), Albert Topf, Uta C. Hoppe, Michael Lichtenauer	41
10	Skeletal Muscle Function, Structure, and Metabolism in Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction 2020 ·Circulation Heart Failure ·Tarek Bekfani, Mohamed M. Bekhite, Steffen Derlien, (unknown), Martin Westermann, Sándor Nietzsche, Ali Hamadanchi, (unknown), Julian Westphal, Daniela Haase, (unknown), Peter Schlattmann, U. Smolenski, Michael Lichtenauer, Bernhard Wernly, Peter Jirak, Gabriele Lehmann, Sven Möbius‐Winkler, P. Christian Schulze	57
11	Infective endocarditis – A review of current therapy and future challenges 2020 ·Hellenic Journal of Cardiology ·Richard Rezar, Michael Lichtenauer, (unknown), (unknown), Jan Marco Kern, Zhichao Zhou, (unknown), (unknown), Bernhard Strohmer, Uta C. Hoppe, Bernhard Wernly	20
12	Regenerative Cardiovascular Therapies: Stem Cells and Beyond 2019 ·International Journal of Molecular Sciences ·Bernhard Wernly, Moritz Mirna, Richard Rezar, Christine Prodinger, Christian Jung, Bruno K. Podesser, Attila Kiss, Uta C. Hoppe, Michael Lichtenauer	42
13	Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity 2018 ·Journal of Investigative Medicine ·(unknown), Michael Lichtenauer, Bernhard Wernly, Vera Paar, Uta C. Hoppe, (unknown), Monika Fritzer‐Szekeres, Brigitte Litschauer, Jeanette Strametz‐Juranek	9
14	Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease 2018 ·Heart and Vessels ·Christoph Edlinger, Michael Lichtenauer, Bernhard Wernly, Rudin Pistulli, Vera Paar, Christine Prodinger, (unknown), Marcus Thieme, Jürgen Kammler, Christian Jung, Uta C. Hoppe, P. Christian Schulze, Daniel Kretzschmar	18
15	Global research trends in the medical therapy of pulmonary arterial hypertension 2000–2014 2016 ·Pulmonary Pharmacology & Therapeutics ·C Schreiber, Christoph Edlinger, Sarah Eder, (unknown), Bernhard Wernly, Ingrid Pretsch, Christian Jung, Uta C. Hoppe, Michael Lichtenauer	3
16	Extraction of a trapped pacemaker lead in a pacemaker-dependent patient 2015 ·Journal of Cardiology Cases ·Alexander Kypta, Hermann Blessberger, Juergen Kammler, Thomas Lambert, Michael Lichtenauer, Clemens Steinwender	2
17	Decrease in Dendritic Cells in Endomyocardial Biopsies of Human Dilated Cardiomyopathy 2013 ·European Journal of Heart Failure ·Rudin Pistulli, Sebastian König, (unknown), Daniel Kretzschmar, Ilonka Rohm, Michael Lichtenauer, Michael Fritzenwanger, Gerhard Mall, Gita Mall, Hans‐Reiner Figulla, Atilla Yılmaz	26
18	Association of inverted Takotsubo cardiomyopathy with postpartum pneumo-mediastinum: when a “broken lung” meets a “broken heart” 2013 ·Wiener klinische Wochenschrift ·Ali Hamadanchi, Michael Lichtenauer, Gudrun Dannberg, Hans‐R. Figulla	1
19	Alpha-Gal Specific IgG Immune Response after Implantation of Bioprostheses 2009 ·The Thoracic and Cardiovascular Surgeon ·Andreas Mangold, Tamás Szerafin, Konrad Höetzenecker, Stefan Hacker, Michael Lichtenauer, (unknown), Stefanie Nickl, Martin Dworschak, Roland Blumer, Jana Auer, Hendrik Jan Ankersmit	45
20	Caspase‐cleaved cytokeratin 18 and 20 S proteasome in liver degeneration 2007 ·Journal of Clinical Laboratory Analysis ·Hubert Hetz, Konrad Höetzenecker, Stefan Hacker, Peter Faybik, Andreas Pollreisz, Bernhard Moser, Georg A. Roth, Wolfram Hoetzenecker, Michael Lichtenauer, Markus Klinger, Claus G. Krenn, Hendrik Jan Ankersmit	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact